Asklepios Bio Pharmaceutical, Inc. announced it raised $200 Million in an initial filing from an offering of $200 Million

May 29, 2019•about 6 years ago

Amount Raised

$200 Million

DurhamBiotechnology

Company Information

Company

Asklepios BioPharmaceutical, Inc.

Location

20 TW ALEXANDER DRIVE

Durham, North Carolina, United States

About

AskBio is a leading, clinical-stage gene therapy company dedicated to developing AAV gene therapies for genetic disorders. Learn more about our gene therapy technology and current clinical trials.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Asklepios Bio Pharmaceutical, Inc. announced it raised $200 Million in an initial filing from an offering of $200 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information